Common · Knowledge
Pharmacogenomics
Study of the role of the genome in drug response
Pharmacogenomics, often abbreviated "PGx", is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of a patient affects their response to drugs.
From Wikipedia
Pharmacogenomics, often abbreviated "PGx", is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of a patient affects their response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response, by correlating DNA mutations (including point mutations, copy number variations, and structural variations) with pharmacokinetic (drug absorption, distribution, metabolism, and elimination), pharmacodynamic (effects mediated through a drug's biological targets), and immunogenic endpoints. Pharmacogenomics aims to develop rational means to optimize drug therapy, with regard to the patients' genotype, to achieve maximum efficiency with minimal adverse effects. It is hoped that by using pharmacogenomics, pharmaceutical drug treatments can deviate from what is dubbed as the "one-dose-fits-all" approach. Pharmacogenomics also attempts to eliminate trial-and-error in prescribing, allowing physicians to take into consideration their patient's genes, the functionality of these genes, and how this may affect the effectiveness of the patient's current or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of precision medicine and even personalized medicine, in which drugs and drug combinations are optimized for narrow subsets of patients or even for each individual's unique genetic makeup. Whether used to explain a patient's response (or lack of it) to a treatment, or to act as a predictive tool, it hopes to achieve better treatment outcomes and greater efficacy, and reduce drug toxicities and adverse drug reactions (ADRs). For patients who do not respond to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic recommendations for a given drug, two possible types of input can be used: genotyping, or exome or whole genome sequencing. Sequencing provides...
Text: Wikipédia, CC BY-SA 4.0. · Image: David Eccles (Gringer) (CC BY 4.0) ·
Related cards
-
★
Physiologically based pharmacokinetic modelling
Modeling the body's responses to drugs
-
★★★★
Pharmacology
Branch of biology concerning drugs
-
★★
Pharmacokinetics of estradiol
Pharmaceutical compound
-
★★
Genomics
Interdisciplinary field of biology
-
★★
Pharmacovigilance
The pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical product
-
★
Pharmacokinetics of progesterone
Pharmaceutical compound